Skip to main content
. 2021 Apr 4;13(7):1714. doi: 10.3390/cancers13071714

Table 1.

Different antibodies and platforms for ICI tested in SCCHN.

ICI Agent Complement PD-L1 Ab Ab Host Species Platform Detection System Diagnostic Cut-Off
Pembrolizumab [59,112] 22C3 murine Dako autostainer Link 48 EnVision FLEX
visualization system
TC or IC ≥1% (CPS)
Nivolumab [18] 28-8 rabbit Dako Autostainer Link 48 OptiView DAB IHC Detection Kit TC >1%, TC >5%
Atezolizumab [123] SP142 rabbit Ventana Benchmark Ultra OptiView DAB IHC Detection Kit TC: ≥ 5%,
IC: ≥ 5%
Durvalumab [60] SP263 rabbit Ventana Benchmark Ultra OptiView DAB IHC Detection Kit/
OptiView Amplification Kit
TC: ≥ 25%
Avelumab [124] 73-10 rabbit Dako autostainer Link 48 OptiView DAB IHC Detection Kit N/A

Ab = antibody; CPS = combined positive score; IC = immune cells; ICI = immune checkpoint inhibition; IHC = immunohistochemistry; N/A = not applicable; SCCHN = squamous cell carcinoma of the head and neck; TC = tumor cells.